Baxter International Inc. (NYSE:BAX – Get Free Report) announced a quarterly dividend on Wednesday, October 28th. Investors of record on Friday, November 27th will be given a dividend of $0.01 per share by the medical instruments supplier on Monday, January 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, November 27th.
Baxter International has decreased its dividend payment by an average of 0.1% per year over the last three years. Baxter International has a dividend payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Baxter International to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.
Baxter International Trading Down 1.4%
Shares of NYSE:BAX opened at $23.16 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 1.39. The company’s 50-day moving average price is $24.65 and its 200 day moving average price is $21.35. The company has a market cap of $11.97 billion, a PE ratio of -11.27, a P/E/G ratio of 3.85 and a beta of 0.65. Baxter International has a fifty-two week low of $15.73 and a fifty-two week high of $30.00.
Baxter International (NYSE:BAX – Get Free Report) last issued its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.06. The business had revenue of $2.98 billion during the quarter, compared to the consensus estimate of $2.91 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The business’s revenue was up 5.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.69 earnings per share. Sell-side analysts anticipate that Baxter International will post 2.04 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in Baxter International during the 2nd quarter worth about $1,744,874,000. Pzena Investment Management LLC acquired a new position in shares of Baxter International during the 2nd quarter worth approximately $1,392,098,000. Equity Investment Corp acquired a new stake in Baxter International during the second quarter worth approximately $146,815,000. Bank of America Corp DE acquired a new position in Baxter International in the 2nd quarter valued at $132,993,000. Finally, Bank of New York Mellon Corp bought a new stake in Baxter International in the 2nd quarter valued at about $68,036,000. 90.19% of the stock is currently owned by institutional investors and hedge funds.
Baxter International Company Profile
Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.
Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.
Featured Articles
- Five stocks we like better than Baxter International
- Advanced Micro Devices’ Meta Platforms Partnership Goes Beyond a $1 Billion Investment
- Chipotle’s $32 Floor: Is a Major Stock Rebound Coming?
- SaaS-Pocalypse II: Is ServiceNow’s Sell-Off Another Buying Opportunity?
- Robinhood Stock Is Down Nearly 37%—So Why Is Wall Street Still So Bullish?
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
